Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.
BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that on January 6, 2025, it received a NYSE American LLC notice indicating...
BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0819 | 13.65 | 0.6 | 0.76 | 0.555 | 275630 | 0.61412153 | CS |
| 4 | 0.1799 | 35.8366533865 | 0.502 | 1.43 | 0.502 | 1215145 | 0.69286464 | CS |
| 12 | 0.1467 | 27.4103139013 | 0.5352 | 1.43 | 0.478 | 531071 | 0.69333089 | CS |
| 26 | -8.0381 | -92.1800458716 | 8.72 | 8.72 | 0.478 | 580026 | 3.64472866 | CS |
| 52 | -9.0731 | -93.0097385956 | 9.755 | 21.5 | 0.478 | 912135 | 8.85015763 | CS |
| 156 | -34.7481 | -98.0753598645 | 35.43 | 50 | 0.478 | 1379194 | 21.45171248 | CS |
| 260 | -72.8181 | -99.072244898 | 73.5 | 111 | 0.478 | 1771786 | 38.64466694 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
